Geode Capital Management
CRDF icon

Geode Capital Management’s Cardiff Oncology CRDF Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.72M Buy
1,498,838
+104,409
+7% +$329K ﹤0.01% 2762
2025
Q1
$4.38M Buy
1,394,429
+411,551
+42% +$1.29M ﹤0.01% 2722
2024
Q4
$4.27M Buy
982,878
+54,646
+6% +$237K ﹤0.01% 2817
2024
Q3
$2.48M Buy
928,232
+17,557
+2% +$46.9K ﹤0.01% 3058
2024
Q2
$2.02M Buy
910,675
+475,842
+109% +$1.06M ﹤0.01% 3127
2024
Q1
$2.32M Buy
434,833
+10,727
+3% +$57.3K ﹤0.01% 3057
2023
Q4
$628K Buy
424,106
+31,799
+8% +$47.1K ﹤0.01% 3528
2023
Q3
$545K Buy
392,307
+11,157
+3% +$15.5K ﹤0.01% 3567
2023
Q2
$560K Sell
381,150
-32,352
-8% -$47.6K ﹤0.01% 3597
2023
Q1
$682K Hold
413,502
﹤0.01% 3526
2022
Q4
$578K Sell
413,502
-870
-0.2% -$1.22K ﹤0.01% 3596
2022
Q3
$638K Buy
414,372
+2,262
+0.5% +$3.48K ﹤0.01% 3598
2022
Q2
$906K Sell
412,110
-257,719
-38% -$567K ﹤0.01% 3472
2022
Q1
$1.66M Buy
669,829
+24,745
+4% +$61.4K ﹤0.01% 3354
2021
Q4
$3.88M Buy
645,084
+62,927
+11% +$378K ﹤0.01% 3032
2021
Q3
$3.88M Buy
582,157
+67,176
+13% +$447K ﹤0.01% 3055
2021
Q2
$3.42M Buy
514,981
+306,526
+147% +$2.04M ﹤0.01% 3108
2021
Q1
$1.93M Buy
208,455
+5,569
+3% +$51.6K ﹤0.01% 3267
2020
Q4
$3.65M Buy
202,886
+96,327
+90% +$1.73M ﹤0.01% 2761
2020
Q3
$1.51M Buy
106,559
+66,283
+165% +$941K ﹤0.01% 3028
2020
Q2
$201K Buy
40,276
+23,695
+143% +$118K ﹤0.01% 3662
2020
Q1
$16K Hold
16,581
﹤0.01% 4048
2019
Q4
$20K Hold
16,581
﹤0.01% 4157
2019
Q3
$25K Hold
16,581
﹤0.01% 4122
2019
Q2
$41K Hold
16,581
﹤0.01% 4100
2019
Q1
$62K Sell
16,581
-82,901
-83% -$310K ﹤0.01% 3977
2018
Q4
$52K Hold
99,482
﹤0.01% 3983
2018
Q3
$81K Buy
99,482
+87,872
+757% +$71.5K ﹤0.01% 3970
2018
Q2
$8K Sell
11,610
-127,720
-92% -$88K ﹤0.01% 4059
2018
Q1
$48K Hold
139,330
﹤0.01% 3953
2017
Q4
$42K Sell
139,330
-10,513
-7% -$3.17K ﹤0.01% 3944
2017
Q3
$109K Hold
149,843
﹤0.01% 3811
2017
Q2
$188K Sell
149,843
-47,616
-24% -$59.7K ﹤0.01% 3708
2017
Q1
$227K Buy
197,459
+9,881
+5% +$11.4K ﹤0.01% 3611
2016
Q4
$393K Buy
187,578
+949
+0.5% +$1.99K ﹤0.01% 3358
2016
Q3
$837K Buy
186,629
+2,681
+1% +$12K ﹤0.01% 3030
2016
Q2
$833K Buy
183,948
+506
+0.3% +$2.29K ﹤0.01% 2996
2016
Q1
$853 Buy
183,442
+2,363
+1% +$11 ﹤0.01% 2967
2015
Q4
$977K Buy
181,079
+5,956
+3% +$32.1K ﹤0.01% 2925
2015
Q3
$996K Buy
175,123
+32,678
+23% +$186K ﹤0.01% 2870
2015
Q2
$1.45M Buy
142,445
+44,375
+45% +$450K ﹤0.01% 2696
2015
Q1
$667K Buy
98,070
+15,971
+19% +$109K ﹤0.01% 3064
2014
Q4
$353K Buy
82,099
+16,605
+25% +$71.4K ﹤0.01% 3344
2014
Q3
$299K Hold
65,494
﹤0.01% 3404
2014
Q2
$229K Hold
65,494
﹤0.01% 3470
2014
Q1
$375K Hold
65,494
﹤0.01% 3270
2013
Q4
$375K Hold
65,494
﹤0.01% 3203
2013
Q3
$470K Buy
65,494
+27,675
+73% +$199K ﹤0.01% 2983
2013
Q2
$264K Buy
+37,819
New +$264K ﹤0.01% 3134